Back to search
FDAFDA · Food and drugs·Recall number Z-2620-2017

Merge OrthoPACS software.

Published June 28, 2017 · Recall initiated: May 24, 2017

Summary

FDA records medical device Class II recall Z-2620-2017, published June 28, 2017 and initiated May 24, 2017. Recalling firm: Merge Healthcare, Inc.; Status: Terminated; Reported quantity: 98 sites potentially have the affected versions; Lot: Versions 6.6, 6.6.1, and 6.6.2. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

A migrated study that has annotations will display the annotations, but when a prior study is loaded that should have annotations, the second study will not display annotations.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Merge Healthcare, Inc.
Distributor
Distribution was made nationwide to medical facilities. There was no foreign/government/military distribution.
Lot
Versions 6.6, 6.6.1, and 6.6.2
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Merge OrthoPACS software. recalled?

Yes. FDA published recall Z-2620-2017 on June 28, 2017. Reported hazard: A migrated study that has annotations will display the annotations, but when a prior study is loaded that should have annotations, the second study will not display annotations.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit